Inhalation drug delivery is a core competency at Aptar Pharma. We provide end-to-end support for the development of Inhalation drug delivery products from early-stage pre-formulation work to finished product release testing.
Inhalation Devices
Inhalation devices play a crucial role in the effective treatment of respiratory diseases such as asthma and COPD. Aptar Pharma offers a range of innovative inhaler devices designed to deliver medications directly to the lungs, providing rapid relief and improving patient outcomes.
Our portfolio includes pressurized Metered Dose Inhalers (pMDIs), which are commonly used for asthma and COPD management. These inhalers deliver a precise dose of medication with each actuation, ensuring accurate dosing and consistent drug delivery. Aptar Pharma works closely with inhaler manufacturers to develop customized pMDI solutions that meet the specific needs of their drug formulations and target patient populations.
With a broad range of advanced inhalation devices combined with comprehensive support services, Aptar Pharma is an award-winning partner to innovator companies in the Orally Inhaled and Nasal Drug Product (OINDP) product space. Our inhaler drug delivery device technologies underpin some of the most successful commercially approved asthma and COPD therapeutics on the market. Whether it’s accelerating bringing your new asthma inhaler product to market or it’s repositioning an existing product into a more sustainable formulation, Aptar Pharma is your ideal partner for inhaler drug delivery solutions.
Inhaler Device Manufacturer
As a leading inhaler device manufacturer, Aptar Pharma is committed to advancing inhalation drug delivery technology. We collaborate with pharmaceutical companies to develop next-generation inhalers that enhance patient convenience, improve medication adherence, and optimize drug delivery efficiency.
Our expertise in inhalation device design and manufacturing allows us to offer innovative solutions tailored to meet the evolving needs of the respiratory market. Whether you’re developing a new asthma inhaler or looking to improve an existing COPD inhaler, Aptar Pharma has the capabilities and experience to support your project from concept to commercialization.
Metered Dose Inhalers (MDIs)
Metered Dose Inhalers (MDIs) are a popular choice for delivering medication to the lungs due to their convenience and portability. Aptar Pharma specializes in the development of MDIs for the treatment of asthma, COPD, and other respiratory conditions.
Our MDIs are designed to deliver a precise dose of medication with each actuation, ensuring consistent drug delivery and optimal therapeutic outcomes. We work closely with pharmaceutical companies to develop customized MDI solutions that meet their specific formulation requirements and target patient populations.
Conclusion
Inhalation drug delivery is a critical component of respiratory therapy, and Aptar Pharma is dedicated to advancing the field through innovative inhaler devices and comprehensive support services. Whether you’re developing a new asthma inhaler or seeking to improve an existing COPD inhaler, Aptar Pharma has the expertise and capabilities to support your project from concept to commercialization. Contact us today to learn more about our inhaler drug delivery solutions and how we can help bring your product to market.
